Allied Biotech Corporation (TPEX:1780)

Allied Biotech Revenue

Allied Biotech had revenue of 258.15M TWD in the quarter ending June 30, 2026, with 19.67% growth. This brings the company's total for the last twelve months to 922.49M, up 14.67% year-over-year. In the year 2025, Allied Biotech had annual revenue of 849.51M with 5.28% growth. That makes Allied Biotech the 31,677th largest company in the world by revenue and 1,614th in Taiwan.

• Revenue (ttm): 922.49M
• Revenue Growth: +14.67%
• P/S Ratio: 2.79
• Revenue / Employee: 23.06M
• Employees: 40
• Market Cap: 2.57B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Manufacture and Sale of Carotenoids in Taiwan 778.61M 59.3%
• Sale of Carotenoids in Europe 478.19M 36.4%
• Sale of Carotenoids in China 57.16M 4.4%

By Geography

Chart

• Europe 477.59M 56.2%
• America 148.30M 17.5%
• Asia 140.66M 16.6%
• Others 82.96M 9.8%

Fiscal year ended Dec 31, 2025 See the full Allied Biotech breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	849.51M	42.59M	5.28%
Dec 31, 2024	806.92M	86.49M	12.00%
Dec 31, 2023	720.43M	3.69M	0.51%
Dec 31, 2022	716.75M	39.99M	5.91%
Dec 31, 2021	676.76M	58.69M	9.50%

Data Source: S&P Global Market Intelligence Last updated: Aug 7, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 17, 2026

Data Sources Report a data error